CVR: 21142743
Secondary names: CCBR A/S
The financial health of Center for Clinical and Basic Research A/S appears to be precarious, with significant fluctuations in revenue and profitability over the past five years. Revenue peaked at 94.36 million DKK in 2021 but has since declined sharply to 2.13 million DKK in 2025, while profit margins have swung from a loss of 23.76 million DKK in 2021 to a loss of 7.41 million DKK in 2025. The company's equity position remains concerning, with negative equity reaching -37.63 million DKK in 2021 and improving slightly to -16.37 million DKK by 2025. These trends indicate a challenging trajectory within the research and experimental development sector, highlighting the need for strategic adjustments to stabilize operations and improve financial viability.
AI-generated summary
Selskabets formål er at drive konsulentvirksomhed, investeringsvirksomhed og forskning samt hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2.1 mio. | -7.4 mio. | 94.6 mio. | -16.4 mio. | 0 | |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Companies in the same industry and area
CVR 43901885
CVR 45796256
CVR 18631776
CVR 39955490
CVR 44742438
companydata.dk